A detailed history of Bank Plus Trust Department transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Bank Plus Trust Department holds 11,724 shares of EW stock, worth $1.01 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
11,724
Previous 11,907 1.54%
Holding current value
$1.01 Million
Previous $931 Million 2.09%
% of portfolio
0.24%
Previous 0.28%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 17, 2025

SELL
$73.75 - $81.83 $13,496 - $14,974
-183 Reduced 1.54%
11,724 $912 Million
Q2 2025

Jul 23, 2025

BUY
$67.07 - $78.22 $26,224 - $30,584
391 Added 3.4%
11,907 $931 Million
Q1 2025

May 01, 2025

BUY
$67.95 - $76.19 $7,814 - $8,761
115 Added 1.01%
11,516 $835 Million
Q4 2024

Feb 04, 2025

BUY
$64.54 - $75.92 $735,820 - $865,563
11,401 New
11,401 $844 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $53.4B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Bank Plus Trust Department Portfolio

Follow Bank Plus Trust Department and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Plus Trust Department, based on Form 13F filings with the SEC.

News

Stay updated on Bank Plus Trust Department with notifications on news.